No US IPO prices this week — Hong Kong's chip offer closes tomorrow
The first full week of Q4 has no US IPO set to price, Nscale's $2 billion AI data-center listing is the biggest deal waiting in the pipeline, and Hong Kong's ESWIN Computing offer closes Tuesday at noon.
The US IPO market opened the fourth quarter with nothing to buy. As of Monday morning, no operating company is set to price a US listing this week, and the only deal on the near calendar is a blank-check offering: AfterNext Acquisition I Corp., a SPAC due to price Wednesday. 12
So this is a waiting week in the US. The last sizable deal before the pause priced below its range and stayed there, and four offerings have now been pulled rather than priced since mid-September. Hong Kong has the one subscription still open — a RISC-V chipmaker whose offer closes Tuesday at noon. 3
Today's spotlight: Nscale (NSCL)
Status: Filed, not yet priced. Nscale filed its registration statement with the SEC on September 18; on Renaissance Capital's estimate the deal could raise about $2.0 billion. It plans to list on the New York Stock Exchange under the ticker NSCL, and no price range has been set. Renaissance counts it among the few companies eligible to launch in the week ahead. 45
The business in one sentence: Nscale is a British "neocloud" that prepares land, builds its own power generation and liquid-cooled data centers, installs and runs the GPUs inside them, and sells that capacity mostly under long-term, take-or-pay contracts to hyperscalers and AI labs, with a smaller cloud business selling managed AI services. 4
Why it matters to a retail account: It is the largest US listing in the pipeline, and it sits in the same AI-data-center theme as the deals retail investors could actually buy this fall. If it launches, it becomes the next real test of whether buyers still want to fund AI infrastructure after a September that ended with postponed offerings. 45
The number to watch: $163 million. That is Nscale's revenue for the twelve months ended June 30, 2026 — the sales base behind an offering that could raise roughly $2.0 billion. 4 It is the fastest-growing kind of IPO story and the most fragile: a huge contracted build-out resting on a small revenue base today.
The risk: Customer concentration. Nearly all of Nscale's revenue comes from take-or-pay contracts with a small set of hyperscalers and frontier AI labs — Microsoft and Anthropic are its anchor customers, with multi-year agreements together worth up to roughly $88 billion, and Figure signed as a third. The company was founded in 2024, and as of August 31 its five active data centers were all in Europe: three in Norway, one in Portugal and one in Iceland. A slowdown at one anchor customer, or a slip in its construction program, would hit the whole story. 4
Subscription status: Not open. There is no price range and no public retail allocation to request yet. A retail investor cannot act on this deal today; it becomes actionable only if terms are set and a broker — Robinhood, Fidelity, Schwab, E*TRADE or Webull — offers it through an IPO access program. 46
Actionable now
Verified open US IPO allocations: 0. An allocation counts as actionable here only when five fields line up — a ticker, a confirmed price, a deal-specific minimum buy-in, an order deadline, and a broker that will take the order. Nothing in the US meets that bar this week, because no operating company is in its pricing window. 12
| Offer | Ticker and price | Minimum buy-in | Order deadline | Retail order path |
|---|---|---|---|---|
| AfterNext Acquisition I Corp. | AFNXU; $10.00; 10.0M units; about $100M | Unpublished | Prices Oct 7 27 | Unpublished; blank-check IPO led by EarlyBirdCapital 7 |
| Nscale | NSCL; no price range filed | Unpublished | Not set | Unnamed 4 |
| Surface checked today | What it exposed | Verifiable order path |
|---|---|---|
| Webull IPO Center | Seven tracked offerings with price ranges but no deal minimum or order cutoff | None 8 |
| Nasdaq IPO calendar feed | Priced, upcoming and filed tables; the only October upcoming row is the AfterNext SPAC | No retail fields 2 |
| Renaissance Capital calendar | Nothing set to price this week or next; three early-October filings | No retail fields 1 |
| Robinhood IPO Access (public page) | Explains how allocations work, but lists no open deals | Deals surface only inside the app, and only when Robinhood participates 6 |
Market pulse
- Accelevation finished its first week below its offer price. The data-center power company priced at $18 — under its $20–$24 range — on September 29, and closed its first week down about 2%. 9 It was the only sizable US IPO to reach the market in the past two weeks.
- The fall calendar keeps losing deals. Oura postponed its $2.1 billion offer on September 29 — the fourth US deal pulled in two weeks — and Renaissance Capital's third-quarter review says the fall pickup "stumbled" on AI-spending worries, a 19-year high in bond yields and resumed rate hikes. Q3 produced 30 US listings and $32.8 billion in proceeds, but $26.5 billion of that was memory-chip maker SK hynix alone; strip that out and everything else raised $6.2 billion. 10 For the year through October 1, Renaissance's IPO index was up 16.4% against 13.0% for the S&P 500 — the market overall is fine; it is the newest deals that are struggling. 5
- The next mega-listing is reportedly lining up. Renaissance reports that AI giant Anthropic is firming up its listing timeline, with marketing expected as soon as the week of November 9. 5 No terms or price range have been set, so treat it as a calendar event to watch rather than something to act on.
HK desk
One public subscription is open in Hong Kong, and it closes tomorrow.
| Code and company | Offer price | Board lot and entry cash | Public close | Listing |
|---|---|---|---|---|
| 01256 ESWIN Computing | HK$1.48–HK$1.59 | 2,000 shares; HK$3,212.07 | Noon HKT, Oct 6 | Oct 9 3 |
Beijing ESWIN Computing designs RISC-V chips — human-machine-interaction and multimedia chips for televisions, monitors, laptops, phones and watches, and connectivity and computing chips for cars, robots and industrial equipment — and outsources the manufacturing, packaging and testing. 3 It calls itself China's largest domestic supplier of smart-device human-machine-interaction chip products by 2025 revenue. 3 The offer covers 1.57 billion H shares, 157.02 million of them for the Hong Kong tranche, and expects net proceeds of about HK$2.27 billion at HK$1.54 — 35% for new chip products, 30% for its RISAA platform, 15% for acquisitions, 10% for marketing and 10% for working capital. 3 CITIC Securities (Hong Kong) and China Securities (International) sponsor the deal, and the price is set Wednesday. 3
September's listings have cooled. Camsense (06802) closed Monday at HK$118.10, about double its HK$58.85 offer — but well under the HK$215.20 it closed its first day, so the debut spike has given back more than a third. 11 Kinwong (03228) and Direct Drive (06731) are up about 16% and 19% from their offers, while RA Materials (09607) is down about 8% and Transwarp (06727) about 34% from HK$49.00. 11
On the radar: October 5 to 19
Renaissance Capital has no operating company set to price in the next two weeks, so this is the scheduled and filed pipeline, with a source-stated timing wherever one exists. 1
| Deal | Pricing | Expected listing | Terms | Why watch |
|---|---|---|---|---|
| AfterNext Acquisition I Corp. (AFNXU) | Oct 7 | Oct 7 | 10.0M units at $10.00; about $100M | Blank-check company led by EarlyBirdCapital 27 |
| Bitari (BIAI) | week of Oct 14 | undisclosed | 4.3M shares; $7.00; about $30M | US Tiger Securities leads 7 |
| Web3Labs Global (MDAT) | week of Oct 19 | undisclosed | 6.3M shares; $4.00–$5.00; about $28M | Hong Kong-based Web3 company; Eddid Securities USA leads 7 |
| Nscale (NSCL) | undisclosed | undisclosed | filed for about $2.0B; NYSE | Largest US deal in the pipeline; AI data-center developer 45 |
Just outside the two-week window, IPOScoop lists BW Industrial Holdings (BWGC, $6.00–$7.00) and Primagrove (YNTE, $4.00–$6.00) for the week of October 26; both are small, Hong Kong-linked deals led by Eddid Securities. 7 Renaissance also flags autoimmune biotech TRex Bio and cancer biotech Iambic Therapeutics as the most likely candidates to launch in the near term. 5
Market information only, not investment advice. IPO terms, dates, retail allocation availability and opening prices can change.
References
- 1Renaissance Capital IPO Calendar
renaissancecapital.com
- 2Nasdaq IPO calendar data feed
api.nasdaq.com
- 3ET Net: ESWIN Computing 01256
etnet.com.hk
- 4Renaissance Capital: Nscale files for an estimated $2.0 billion US IPO
renaissancecapital.com
- 5Renaissance Capital: US IPO Week Ahead, October 2
renaissancecapital.com
- 6Robinhood: About IPO Access
robinhood.com
- 7IPOScoop IPO Calendar
iposcoop.com
- 8Webull IPO Center
webull.com
- 9Renaissance Capital: US IPO Weekly Recap, October 2
renaissancecapital.com
- 10Renaissance Capital: 3Q 2026 US IPO Market Review
renaissancecapital.com
- 11ET Net IPO Page
etnet.com.hk
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.